Poll: Are you Using Surgical Mesh for POP or Stress Urinary Incontinence?
The FDA issued a public health notification regarding use of surgical mesh for the repair of pelvic organ prolapsed and stress urinary incontinence. Surgical mesh has caused severe complications in some patients.
The FDA has issued a public health notification regarding use of surgical mesh for the repair of pelvic organ prolapsed and stress urinary incontinence. Surgical mesh has caused severe complications in some patients. While a lawsuit is pending, surgical mesh is still being used. The FDA recommends physicians obtain specialized training and be aware of the potential risks, thoroughly inform patients of adverse risks, and monitor patients closely for complications.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
